Quantcast

Latest Artificial pacemaker Stories

2011-01-03 12:20:00

WOODCLIFF LAKE, N.J., Jan. 3, 2011 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it began shipping the 225mg, 325mg, and 425mg strengths of propafenone SR capsules, the generic version of GlaxoSmithKline's Rythmol SR®. Par has been awarded 180 days of marketing exclusivity, commencing at launch, for being the first to file an ANDA containing a paragraph IV certification for the product. According to IMS Health data, annual sales in...

2010-12-02 07:00:00

SANTA CLARA, Calif., Dec. 2, 2010 /PRNewswire/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiovascular diagnostic solutions developer, announced today that Dr. Dorin Panescu, Chief Technical Officer and Vice President Research and Development, has been named an IEEE Fellow, effective January 1, 2011. The IEEE Grade of Fellow is conferred by the IEEE Board of Directors upon a person with an outstanding record of accomplishments in any of the IEEE fields of interest. The total...

2010-11-22 20:47:21

Study Highlights:     * Survival rates for patients with implanted defibrillators and resynchronization devices in the general population are similarly high as rates in clinical trial settings.    * Remote monitoring of the devices over a network is linked to improved survival odds. Implanted devices that treat cardiac dysfunction in heart failure patients are as successful in "real world" use as they are in controlled clinical trial settings, according to a...

2010-11-18 07:30:00

KING OF PRUSSIA, Pa., Nov. 18, 2010 /PRNewswire/ -- Prism Pharmaceuticals, Inc. announced today that the U.S. Food & Drug Administration (FDA) has approved the supplemental new drug application for NEXTERONE® (amiodarone HCl) Premixed Injection, the first and only premixed intravenous (IV) bag formulation of the antiarrhythmic agent amiodarone IV. NEXTERONE Premixed Injection is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular...

2010-11-15 13:35:56

Findings pave way for better understanding of abnormal heart rhythms and sudden cardiac death Scientists studying genetic data from nearly 50,000 people have uncovered several DNA sequence variations associated with the electrical impulses that make the heart beat. The findings, reported in Nature Genetics, may pave the way for a greater understanding of the mechanisms for abnormal heart rhythms and sudden cardiac death. "Regulation of the heart's rhythm is exceedingly complex," says...

e2b4c9d724e70b9bb3a2b89440bfbf1b1
2010-10-20 09:05:00

University of Michigan Cardiovascular Center examines logistics of safe, cost-effective pacemaker donation Millions worldwide die each year because they can't afford a pacemaker. Meanwhile heart patients in the United States say they'd be willing to donate theirs after death to someone in need. In the current issue of Circulation, experts at the University of Michigan Cardiovascular Center examine the legality and logistics of collecting pacemakers, after they are removed for burial or...

2010-10-12 16:41:07

In a Canadian first, the Peter Munk Cardiac Centre used a new kind of left ventricular assist device (LVAD) to treat a patient with advanced heart failure. The new device is longer lasting than older generation LVADs and may eliminate the need for a second LVAD "“ a major drawback with the old technology. The patient, 61-year-old Marva Lorde of Mississauga, suffered a heart attack in 2007 and underwent several treatments for heart failure "“ including a 10-day intensive care unit...

2010-10-06 07:07:00

TORONTO, Oct. 6 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, growth in the $2 billion US cardiac resynchronization therapy defibrillator market will be supported by the expanded approval of Boston Scientific's chronic resynchronization therapy defibrillators in New York Heart Association class I and II patients. The New York Heart Association classification system ranks heart failure patients according to...

2010-09-22 13:35:00

SHREWSBURY, N.J., Sept. 22 /PRNewswire/ -- Angel Medical Systems announced today that it has received CE (Conformite Europeenne) Mark approval for the commercial sale of The AngelMed Guardian System in Europe. The Guardian System is an implantable early warning system designed to detect coronary occlusion from thrombotic events such as plaque ruptures and alert the patient, often before symptom onset. The System is comprised of an internal implantable device about the size of a pacemaker...

2010-09-21 06:29:00

DALLAS, September 21, 2010 /PRNewswire/ -- ReportsandReports announces it will carry U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 Research Report in its store. Browse the complete Report on: http://www.reportsandreports.com/reports/34141-us-market-for-cardiac-rhythm-m anagement-electrophysiology-and-.html Search More Then 50000 Market Research Reports at ReportsandReports (http://www.reportsandreports.com/) Browse All IData Research...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related